AKT1 and glioblastoma: We used the AKT phosphorylation agonist SC79 for rescue experiments to further verify whether the antitumor activity of GNE-477 was mediated by regulating the PI3K-AKT-mTOR signaling pathway and found that GNE-477 regulated this pathway in GBM cells.